Anthropic is set to release an AI web design tool this week, causing an exchange stock prices to drop over 2%.
According to 1M AI News monitoring,
The design tool is aimed at both technical and non-technical users, enabling the creation of presentations, websites, landing pages, and product pages through natural language prompts. It directly competes with AI presentation tool Gamma and Google's AI design tool Stitch.
The report also revealed that Opus 4.7 is not Anthropic's current most powerful model. Internally, there is another model called Claude Mythos, known for its advanced cybersecurity capabilities, currently being used by a few early partners to detect software security vulnerabilities. An Anthropic spokesperson declined to comment.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
3D printing materials supplier Amaero (AMRO.US) restarts US IPO, fundraising drops 60% to $20 million
Amaero (AMRO.US) on Thursday resumed its initial public offering (IPO) plans in the United States and filed new documents with the U.S. Securities and Exchange Commission (SEC), revealing a reduced number of shares to be issued.
Even with Eli Lilly's endorsement, TRex Bio (TRXB.US) struggles to enjoy a premium, as the issue price drops to the lower limit of $14.
Early-stage biotechnology company TRex Bio has priced its IPO at the lower end of the range at $14 per share, raising $116.7 million and achieving a market capitalization of $384 million. The company will be listed on Nasdaq on Friday, with Eli Lilly expressing interest in increasing its stake.
Small molecule biotechnology company Iambic Therapeutics (IAM.US) IPO priced at $15-17 per share, aiming to raise $150 millions.
Iambic Therapeutics plans to raise $150 millions by issuing 9.4 million shares, with an offering price range of $15 to $17 per share.
Crypto prices
More
